CAS 1402821-41-3

Fórmula: C18H26N6OS

InChI: InChI=1S/C18H26N6OS/c1-4-8-24-11-20-15-16(19-9-14-7-6-12(3)26-14)22-18(23-17(15)24)21-13(5-2)10-25/h6-7,11,13,25H,4-5,8-10H2,1-3H3,(H2,19,21,22,23)/t13-/m1/s1

Chave InChI: DPTXJOUVBMUSGY-CYBMUJFWSA-N

SMILES: CCCN1C=NC2=C(N=C(N=C21)N[C@H](CC)CO)NCC3=CC=C(S3)C

GV-58

CAS: 1402821-41-3

GV-58 agonizes N/P-Q-type Ca2+ channels (EC50: 7.21/8.81 μM) with 20x less inhibition on CDK kinases.

Fórmula: C₁₈H₂₆N₆OS

Pureza: 97.36%

Cor e Forma: Yellow Solid

Peso molecular: 374.504

Ref: TM-T11517

GV-58

CAS: 1402821-41-3

GV-58

Fórmula: C₁₈H₂₆N₆OS

Pureza: ≥95%

Peso molecular: 374.5

Ref: 54-BUP12808

GV-58

CAS: 1402821-41-3

Fórmula: C₁₈H₂₆N₆OS

Peso molecular: 374.5

Ref: 7W-GL8315

(R)-2-((6-(((5-Methylthiophen-2-yl)methyl)amino)-9-propyl-9H-purin-2-yl)amino)butan-1-ol

CAS: 1402821-41-3

Fórmula: C₁₈H₂₆N₆OS

Pureza: %

Peso molecular: 374.5036

Ref: IN-DA009CI7

(R)-2-((6-(((5-Methylthiophen-2-yl)methyl)amino)-9-propyl-9H-purin-2-yl)amino)butan-1-ol

CAS: 1402821-41-3

Pureza: 98+%

Cor e Forma: Solid

Peso molecular: 374.5100098

Ref: 10-F870100

GV-58

CAS: 1402821-41-3

GV-58 is a molecule that has been shown to have physiological levels in the brain. GV-58 is an active analog of a neurotransmitter and has been shown to disrupt physiological levels of neurotransmission. GV-58 has also been shown to cause symptoms such as spontaneous activity, disrupted sleep cycles, and spontaneous physical activity. This drug has also been shown to be effective against cancer cells in culture and animal models. More research is needed to determine if this drug is safe for use in humans.

Fórmula: C₁₈H₂₆N₆OS

Pureza: Min. 95%

Peso molecular: 374.5 g/mol

Ref: 3D-CGC82141